10-Q – Page 77 – China Stock Advice

GSI [GENERAL STEEL] 10-Q: Table of Contents Page Part I. FINANCIAL INFORMATION

[Table of Contents Page Part I. FINANCIAL INFORMATION Item 1. Unaudited Financial Statements. Condensed Consolidated Balance Sheets as of September 30, 2015 and December 31, 2014. 3 Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Nine Months Ended September 30, 2015 and 2014. 4 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September] [18 U.S.C. SECTION 1350, SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Yunshan Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of General Steel Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the] [18 U.S.C. SECTION 1350, SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, John Chen, certify that: 1. I have reviewed this quarterly report on Form 10-Q of General Steel Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 1) 2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 Yunshan Li Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 1) 2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 John Chen Chief Financial Officer]

By info| 2016-04-02T14:24:49+00:00 December 28th, 2015|Categories: Chinese Stocks, GSI, Webplus ver|Tags: 0001239188, 10-Q, 2015-12-28, 3310, GSI, STEEL WORKS, BLAST FURNACES and ROLLING and FINISHING MILLS|0 Comments

CCCR [China Commercial Credit] 10-Q: (Original Filing)

[CHINA COMMERCIAL CREDIT, INC. FORM 10-Q INDEX Page Number 3 PART I. FINANCIAL INFORMATION 4 Item 1. Financial Statements 4 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 42 Item 3. Quantitative and Qualitative Disclosures About Market Risk 65 Item 4. Controls and Procedures 65 PART II. OTHER INFORMATION 67 Item 1. Legal Proceedings 67] [I, Jingen Ling, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2015 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [I, Long Yi, certify that: 1 I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2015 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jingen Ling Chief Executive Officer] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Long Yi Chief Financial Officer (Principal Financial and Accounting Officer)]

By info| 2016-03-16T17:19:17+00:00 November 23rd, 2015|Categories: CCCR, Chinese Stocks, SEC Original|Tags: 0001556266, 10-Q, 2015-11-23, 6021, CCCR, NATIONAL COMMERCIAL BANKS|0 Comments

CCCR [China Commercial Credit] 10-Q: CHINA COMMERCIAL CREDIT, INC. FORM 10-Q INDEX Page

[CHINA COMMERCIAL CREDIT, INC. FORM 10-Q INDEX Page Number 3 PART I. FINANCIAL INFORMATION 4 Item 1. Financial Statements 4 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 42 Item 3. Quantitative and Qualitative Disclosures About Market Risk 65 Item 4. Controls and Procedures 65 PART II. OTHER INFORMATION 67 Item 1. Legal Proceedings 67] [I, Jingen Ling, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2015 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [I, Long Yi, certify that: 1 I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2015 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jingen Ling Chief Executive Officer] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Long Yi Chief Financial Officer (Principal Financial and Accounting Officer)]

By info| 2016-03-16T17:20:33+00:00 November 23rd, 2015|Categories: CCCR, Chinese Stocks, Webplus ver|Tags: 0001556266, 10-Q, 2015-11-23, 6021, CCCR, NATIONAL COMMERCIAL BANKS|0 Comments

BSPM [Biostar Pharmaceuticals] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2015 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Ronghua Wang EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Qinghua Liu Qinghua Liu Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]

By info| 2016-03-28T17:42:57+00:00 November 23rd, 2015|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 10-Q, 2015-11-23, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals] 10-Q: FORM 10-Q (Mark One) x September 30, 2015

[FORM 10-Q (Mark One) x September 30, 2015 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Ronghua Wang EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Qinghua Liu Qinghua Liu Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]

By info| 2016-03-28T17:44:36+00:00 November 23rd, 2015|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 10-Q, 2015-11-23, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

ALN [American Lorain] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) September 30, 2015 For the quarterly period ended: 001-34449 Commission File No. AMERICAN LORAIN CORPORATION Nevada 87-0430320 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) BeihuanZhong Road Junan County Shandong, Peoples Republic of China, 276600 (86) 539-7317959 Large accelerated filer [_] Accelerated filer [_] Non-accelerated filer [_] Smaller reporting company [X] (Do] [CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER I, Si Chen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2015 of American Lorain Corporation. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [CERTIFICATIONS OF CHIEF FINANCIAL OFFICER I, Xiang Zhou, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2015 of American Lorain Corporation 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. (Principal Financial Officer and Principal Accounting Officer)]

By info| 2016-04-03T02:27:05+00:00 November 20th, 2015|Categories: ALN, Chinese Stocks, SEC Original|Tags: 0001117057, 10-Q, 2015-11-20, 2030, ALN, CANNED, FROZEN and PRESERVED FRUIT, VEG and FOOD SPECIALTIES|0 Comments

ALN [American Lorain] 10-Q: FORM 10-Q (Mark One) September 30, 2015 For

[FORM 10-Q (Mark One) September 30, 2015 For the quarterly period ended: 001-34449 Commission File No. AMERICAN LORAIN CORPORATION Nevada 87-0430320 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) BeihuanZhong Road Junan County Shandong, Peoples Republic of China, 276600 (86) 539-7317959 Large accelerated filer [_] Accelerated filer [_] Non-accelerated filer [_] Smaller reporting company [X] (Do] [CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER I, Si Chen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2015 of American Lorain Corporation. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [CERTIFICATIONS OF CHIEF FINANCIAL OFFICER I, Xiang Zhou, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2015 of American Lorain Corporation 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. (Principal Financial Officer and Principal Accounting Officer)]

By info| 2016-04-03T02:28:02+00:00 November 20th, 2015|Categories: ALN, Chinese Stocks, Webplus ver|Tags: 0001117057, 10-Q, 2015-11-20, 2030, ALN, CANNED, FROZEN and PRESERVED FRUIT, VEG and FOOD SPECIALTIES|0 Comments

CREG [CHINA RECYCLING ENERGY] 10-Q:

[] [CERTIFICATIONS I, Guohua Ku, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Recycling Energy Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATIONS I, Yongjiang Shi, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Recycling Energy Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Guohua Ku Chairman of the Board and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Yongjiang Shi Chief Financial Officer and Secretary]

By info| 2016-03-14T14:31:54+00:00 November 16th, 2015|Categories: Chinese Stocks, CREG, Webplus ver|Tags: 0000721693, 10-Q, 2015-11-16, 7389, CREG, SERVICES-BUSINESS SERVICES, NEC|0 Comments

SORL [SORL Auto Parts] 10-Q: (Original Filing)

[] [of the Sarbanes-Oxley Act of 2002 I, Xiao Ping Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification of Principal Financial Officer of the Sarbanes-Oxley Act of 2002 I, Zong Yun Zhou, certify that: 1. I have reviewed this quarterly report on Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Dated: November 16, 2015 Xiao Ping Zhang Chief Executive Officer Zong Yun Zhou Chief Financial Officer (Principal Financial Officer)]

By info| 2016-03-18T20:36:58+00:00 November 16th, 2015|Categories: Chinese Stocks, SEC Original, SORL|Tags: 0000714284, 10-Q, 2015-11-16, 3714, MOTOR VEHICLE PARTS and ACCESSORIES, SORL|0 Comments

CPHI [CHINA PHARMA] 10-Q: FORM 10-Q (Mark One) x September 30, 2015

[FORM 10-Q (Mark One) x September 30, 2015 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Nevada 75-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 16, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321093015.htm]

By info| 2016-03-28T19:07:51+00:00 November 16th, 2015|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2015-11-16, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments